Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday's Mid-Day Session

Gainers

  • Altamira Therapeutics Ltd. (NASDAQ:CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets.
  • Biotricity, Inc. (NASDAQ:BTCY) gained 26.3% to $1.20.
  • Snow Lake Resources Ltd. (NASDAQ:LITM) surged 26.3% to $2.59.
  • Amprius Technologies, Inc. (NASDAQ:AMPX) jumped 22.8% to $11.60. Amprius Technologies was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
  • Rockley Photonics Holdings Limited (NYSE:RKLY) gained 20.5% to $0.6287.
  • Veris Residential, Inc. (NYSE:VRE) climbed 20.2% to $14.93 after Kushner Companies made an offer to acquire the company for $16 per share.
  • Huadi International Group Co., Ltd. (NASDAQ:HUDI) surged 19.3% to $37.14.
  • Kaleyra, Inc. (NYSE:KLR) gained 18.9% to $0.8205.
  • Enservco Corporation (NYSE:ENSV) surged 18.3% to $1.74.
  • Intelligent Living Application Group Inc. (NASDAQ:ILAG) gained 17.1% to $2.7518.
  • The Boston Beer Company, Inc. (NYSE:SAM) surged 16.8% to $392.48 after the company reported better-than-expected Q3 adjusted EPS and sales results
  • uCloudlink Group Inc. (NASDAQ:UCL) gained 13.8% to $0.6801.
  • Super League Gaming, Inc. (NASDAQ:SLGG) surged 13.5% to $0.7040.
  • Hawaiian Holdings, Inc. (NASDAQ:HA) shares climbed 12.3% to $15.81. Hawaiian Airlines announced an agreement with Amazon to operate freighter aircraft.
  • Pennsylvania Real Estate Investment Trust (NYSE:PEI) gained 12.2% to $2.9750.
  • FedNat Holding Company (NASDAQ:FNHC) rose 11.2% to $0.6219 after dipping over 8% on Thursday.
  • Novavax, Inc. (NASDAQ:NVAX) climbed 11.1% to $19.09 in sympathy with Pfizer, which is reportedly thinking about increasing the price for COVID-19 boosters.
  • Piedmont Lithium Inc. (NASDAQ:PLL) gained 11% to $59.46.
  • BioNTech SE (NASDAQ:BNTX) gained 9.9% to $130.18 following reports suggesting vaccine makers could possibly raise the prices of COVID-19 shots.
  • Moderna, Inc. (NASDAQ:MRNA) jumped 9.8% to $130.05 after SVB Leerink upgraded the stock from Underperform to Market Perform and raised the price target from $74 to $101.
  • Energy Focus, Inc (NASDAQ:EFOI) shares gained 9.1% to $0.4399. Energy Focus, last month, named Lesley Matt as CEO.
  • Schlumberger Limited (NYSE:SLB) surged 8.9% to $49.77 following upbeat quarterly earnings.
  • Calliditas Therapeutics AB (NASDAQ:CALT) rose 8.3% to $12.45 after dipping 15% on Thursday.
  • Huntington Bancshares Incorporated (NASDAQ:HBAN) surged 8.2% to $14.28 after the company reported better-than-expected Q3 EPS results.
  • Statera Biopharma, Inc. (NASDAQ:STAB) gained 7.6% to $0.1649. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.


Losers

  • Immunic, Inc. (NASDAQ:IMUX) shares dipped 75.3% to $2.2750 after the company reported the pre-planned Phase 1b interim analysis of IMU-935 in psoriasis patients was confounded by a high placebo rate. Two active arms did not separate from the placebo.
  • NextPlay Technologies, Inc. (NASDAQ:NXTP) declined 30% to $0.2898. NextPlay Technologies recently announced its NextFintech division received commitment for a $15 million strategic investment.
  • Tenet Healthcare Corporation (NYSE:THC) dipped 30.4% to $37.78 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 adjusted EPS and sales guidance below estimates.
  • Snap Inc. (NYSE:SNAP) dropped 30.3% to $7.53 following Q3 results. The company said it will not provide Q4 expectations due to uncertainties in the operating environment but believes it is likely that year-over-year revenue growth will decelerate as it moves through Q4. The company also said total time spend watching content in the US decreased 5% year over year.
  • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) fell 23.5% to $7.65. Kala Pharmaceuticals announced a 1-for-50 reverse stock split.
  • Sientra, Inc. (NASDAQ:SIEN) fell 23.3% to $0.3027. Sientra recently announced a proposed public offering.
  • Kalera Public Limited Company (NASDAQ:KAL) dropped 22.3% to $0.3184.
  • SenesTech, Inc. (NASDAQ:SNES) shares fell 21.8% to $0.2191 after declining around 18% on Thursday.
  • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) dipped 21.3% to $3.0950.
  • SVB Financial Group (NASDAQ:SIVB) fell 20.5% to $240.49 after reporting Q3 earnings.
  • Starry Group Holdings, Inc. (NYSE:STRY) declined 20% to $0.8805. Starry announced a 50% workforce reduction and withdrew FY22 guidance.
  • SVB Financial Group (NASDAQ:SIVB) dropped 19.8% to $242.57 after the company reported Q3 earnings results. Following earnings, multiple firms downgraded the stock.
  • COMSovereign Holding Corp. (NASDAQ:COMS) declined 19.6% to $0.0807.
  • Quanergy Systems, Inc. (NYSE:QNGY) fell 19% to $1.53.
  • 9 Meters Biopharma, Inc. (NASDAQ:NMTR) declined 18.2% to $2.2006.
  • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) dropped 18% to $4.1947.
  • Community Health Systems, Inc. (NYSE:CYH) dipped 15.3% to $2.0150.
  • Bit Origin Ltd (NASDAQ:BTOG) fell 15% to $0.2720.
  • Katapult Holdings, Inc. (NASDAQ:KPLT) dropped 14.3% to $0.9430.
  • NLS Pharmaceutics AG (NASDAQ:NLSP) dipped 13.7% to $0.47.
  • Surgery Partners, Inc. (NYSE:SGRY) dropped 12.6% to $22.97.
  • Robert Half International Inc. (NYSE:RHI) shares fell 10.1% to $71.78 after reporting downbeat Q3 earnings.
  • Zovio Inc (NASDAQ:ZVO) fell 9.2% to $0.1772 after declining 7% on Thursday.
  • HCA Healthcare, Inc. (NYSE:HCA) dropped 9.2% to $189.50 after the company reported worse-than-expected Q3 sales results.
  • Select Medical Holdings Corporation (NYSE:SEM) declined 8.3% to $21.62.
  • Pinterest, Inc. (NYSE:PINS) fell 7.1% to $21.35 in sympathy with Snap, which gave an uncertain fourth-quarter outlook.
  • Twitter, Inc. (NYSE:TWTR) shares fell 4.3% to $50.18. The U.S. is reportedly discussing the possibility of subjecting Elon Musk’s companies to national security reviews. Musk has also been locked in a battle over buying Twitter. The U.S. government is reportedly unhappy with the billionaire mobilizing financing from foreign high-net-worth individuals to consummate the deal.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.